Coordinate activation of Shh and PI3K signaling in PTEN-deficient glioblastoma: new therapeutic opportunities

Mariella G. Filbin(Broad Institute), Rosalind A. Segal(Harvard University), Keith L. Ligon(Brigham and Women's Hospital), Marion Dorsch(Biogen (United States)), Sukriti K. Dabral(Harvard University), Shakti Ramkissoon(Foundation Medicine (United States)), David S. Shulman(Harvard University), Maria F. Pazyra‐Murphy(Harvard University), Yoko Franchetti(Dana-Farber Cancer Institute), Silvia Buonamici(New York University), Rameen Beroukhim(Broad Institute), Jean J. Zhao(Harvard University), Navid Redjal(Harvard University), Ekaterina Pak(Harvard University), Andrew L. Kung(Memorial Sloan Kettering Cancer Center), Yu Sun(Harvard University), Jarom Y. Chung(Harvard University), Barbara Tabak, Qi Wang(Hebei Medical University), Yanping Sun(Heilongjiang University of Chinese Medicine), Joseph F. Kelleher(Genomics Institute of the Novartis Research Foundation), Matthew Theisen(Dana-Farber Cancer Institute)
Nature Medicine
September 29, 2013
Cited by 151


Related Papers